XML 42 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating activities    
Net income (loss) $ (25,299) $ 72,741
Adjustments to reconcile to cash provided by operating activities:    
Depreciation, depletion and amortization 31,308 25,273
Accretion on asset retirement obligations 5,006 5,137
Amortization of sales contracts, net   65
Employee stock-based compensation expense 3,962 5,651
Gains on disposals and divestitures, net (214) (475)
Amortization relating to financing activities 971 907
Property insurance recovery related to Mountain Laurel longwall (9,000)  
Changes in:    
Receivables 23,728 7,410
Inventories (19,088) (20,137)
Accounts payable, accrued expenses and other current liabilities (39,201) (17,861)
Income taxes, net (1,073) 76
Other 16,865 6,262
Cash provided by (used in) operating activities (12,035) 84,984
Investing activities    
Capital expenditures (87,690) (39,147)
Minimum royalty payments (62) (63)
Proceeds from disposals and divestitures 233 608
Purchases of short term investments (17,196) (27,902)
Proceeds from sales of short term investments 23,221 26,500
Investments in and advances to affiliates, net (739) (2,196)
Property insurance recovery related to Mountain Laurel longwall 7,353  
Cash used in investing activities (74,880) (42,200)
Financing activities    
Payments on term loan due 2024 (750) (750)
Proceeds from equipment financing 53,611  
Net payments on other debt (5,544) (4,633)
Debt financing costs (422)  
Dividends paid (7,645) (7,839)
Purchases of treasury stock   (75,749)
Payments for taxes related to net share settlement of equity awards (198)  
Cash used in financing activities 39,052 (88,971)
Decrease in cash and cash equivalents, including restricted cash (47,863) (46,187)
Cash and cash equivalents, including restricted cash, beginning of period 153,020 264,937
Cash and cash equivalents, including restricted cash, end of period 105,157 218,750
Cash and cash equivalents, including restricted cash, end of period    
Cash and cash equivalents, including restricted cash, end of period $ 105,157 $ 218,750